Literature DB >> 30105660

Small Intestinal Length Associates with Serum Triglycerides Before and After LRYGB.

Pirjo Käkelä1, Ville Männistö2, Maija Vaittinen3, Sari Venesmaa1, Vesa Kärjä4, Kirsi Virtanen5, Hannu Paajanen1, Jussi Pihlajamäki6,7.   

Abstract

BACKGROUND AND AIMS: Different bariatric procedures have been associated with variable weight loss and decrease in serum levels of lipids and lipoproteins. This variation could be partly related to the length of the small intestinal bypass. We evaluated the association of the small intestinal length with the non-alcoholic fatty liver disease (NAFLD) at baseline and with lipid metabolism before and after laparoscopic Roux-en-Y gastric bypass (LRYGB).
METHODS: Seventy consecutive morbidly obese patients were recruited to this prospective study. A standard 60-cm biliopancreatic limb (BPL) and 120-cm alimentary limb (AL) was performed, and thereafter, the common channel (CC) length was measured during elective LRYGB. Histological analysis of liver biopsy to diagnose NAFLD was performed. The mRNA expression of genes participating in the cholesterol and fatty acid metabolism in the liver was analyzed.
RESULTS: Female sex (p = 0.006), serum triglycerides (TG, p = 0.016), serum alanine aminotransferase (ALT, p = 0.007), and liver steatosis (p = 0.001) associated with the small intestinal length (BPL + AL + CC) at baseline. Association remained significant between levels of serum TG and CC length (p = 0.048) at 1-year follow-up. Liver mRNA expression of genes regulating cholesterol synthesis and bile metabolism did not associate with the baseline small intestinal length.
CONCLUSIONS: Our findings support the suggestions that small intestinal length regulates TG metabolism before and after LRYGB. Therefore, modification of the length of bypassed small intestine based on measured total small intestinal length could optimize the outcomes of the elective LRYGB.

Entities:  

Keywords:  Common channel; LRYGB; Obesity; Small intestinal length; TG; Weight loss

Mesh:

Substances:

Year:  2018        PMID: 30105660     DOI: 10.1007/s11695-018-3447-x

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  31 in total

1.  Change in liver size and fat content after treatment with Optifast very low calorie diet.

Authors:  Mark C Lewis; Madeleine L Phillips; John P Slavotinek; Lilian Kow; Campbell H Thompson; Jim Toouli
Journal:  Obes Surg       Date:  2006-06       Impact factor: 4.129

2.  Small bowel length in hyperlipidemia and massive obesity.

Authors:  I J Guzman; L L Fitch; R L Varco; H Buchwald
Journal:  Am J Clin Nutr       Date:  1977-07       Impact factor: 7.045

3.  Predictors of weight loss and reversal of comorbidities in malabsorptive bariatric surgery.

Authors:  Maria E Valera-Mora; Benedetta Simeoni; Lucilla Gagliardi; Antonino Scarfone; Giuseppe Nanni; Marco Castagneto; Melania Manco; Geltrude Mingrone; Ele Ferrannini
Journal:  Am J Clin Nutr       Date:  2005-06       Impact factor: 7.045

4.  Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch: a randomized trial.

Authors:  Torgeir T Søvik; Erlend T Aasheim; Osama Taha; My Engström; Morten W Fagerland; Sofia Björkman; Jon Kristinsson; Kare I Birkeland; Tom Mala; Torsten Olbers
Journal:  Ann Intern Med       Date:  2011-09-06       Impact factor: 25.391

5.  Surgical treatment of obesity.

Authors:  William Johnson; Eric DeMaria
Journal:  Curr Treat Options Gastroenterol       Date:  2006-04

6.  Long-long limb Roux-en-Y gastric bypass is more efficacious in treatment of type 2 diabetes and lipid disorders in super-obese patients.

Authors:  Jose S Pinheiro; Carlos A Schiavon; Paulo B Pereira; Jose L Correa; Patricia Noujaim; Ricardo Cohen
Journal:  Surg Obes Relat Dis       Date:  2008-06-09       Impact factor: 4.734

7.  Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial.

Authors:  Geltrude Mingrone; Simona Panunzi; Andrea De Gaetano; Caterina Guidone; Amerigo Iaconelli; Giuseppe Nanni; Marco Castagneto; Stefan Bornstein; Francesco Rubino
Journal:  Lancet       Date:  2015-09-05       Impact factor: 79.321

Review 8.  Surgery for weight loss in adults.

Authors:  Jill L Colquitt; Karen Pickett; Emma Loveman; Geoff K Frampton
Journal:  Cochrane Database Syst Rev       Date:  2014-08-08

Review 9.  Endocrine and metabolic complications after bariatric surgery.

Authors:  Anwar A Jammah
Journal:  Saudi J Gastroenterol       Date:  2015 Sep-Oct       Impact factor: 2.485

Review 10.  Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance.

Authors:  Hannele Yki-Järvinen
Journal:  Nutrients       Date:  2015-11-05       Impact factor: 5.717

View more
  3 in total

1.  Early effects of Roux-en-Y gastric bypass on dietary fatty acid absorption and metabolism in people with obesity and normal glucose tolerance.

Authors:  Morten Hindsø; Kirstine Nyvold Bojsen-Møller; Gerrit van Hall; Sten Madsbad; Viggo Bjerregaard Kristiansen; Jens Juul Holst
Journal:  Int J Obes (Lond)       Date:  2022-04-22       Impact factor: 5.551

2.  Proximal Roux-en-Y gastric bypass: Addressing the myth of limb length.

Authors:  Bestoun Ahmed; Wendy C King; William Gourash; Amanda Hinerman; Steven H Belle; Alfons Pomp; Walter J Pories; Anita P Courcoulas
Journal:  Surgery       Date:  2019-08-01       Impact factor: 3.982

Review 3.  The Importance of Intestinal Length in Triglyceride Metabolism and in Predicting the Outcomes of Comorbidities in Laparoscopic Roux-en-Y Gastric Bypass-a Narrative Review.

Authors:  Pirjo Käkelä; Tuomo Rantanen; Kirsi A Virtanen
Journal:  Obes Surg       Date:  2021-04-29       Impact factor: 4.129

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.